极早产儿5分钟Apgar评分与5岁神经发育结局的关系
该研究基于EPICE-SHIPS人群队列(11个欧洲国家19个地区,2011至2012年出生),纳入996例极早产儿(<28周),按5分钟Apgar评分分为0-3、4-6、7-8、9-10分四组。在校正社会人口学变量、围产期因素和严重新生儿疾病后,Apgar评分≤3分(vs 9-10分)与IQ(β=-3.3;95%CI,-10.5至3.8)、ASQ-3(β=-2.1;95%CI,-24.6至20.4)、运动评分(β=-4.0;95%CI,-20.1至12.1)及排除脑瘫患儿后的运动评分(β=0.8;95%CI,-11.7至13.3)均无显著关联。提示极早产儿中低Apgar评分不宜用于预测远期神经发育结局。
要点
- 极早产儿(<28周)5分钟Apgar评分≤3分与IQ无显著关联(β=-3.3;95%CI,-10.5至3.8,vs 9-10分)。
- 5分钟Apgar评分≤3分与ASQ-3评分无显著关联(β=-2.1;95%CI,-24.6至20.4,vs 9-10分)。
- 5分钟Apgar评分≤3分与运动评分无显著关联(β=-4.0;95%CI,-20.1至12.1,vs 9-10分)。
- 排除脑瘫患儿后,5分钟Apgar评分≤3分与运动评分仍无显著关联(β=0.8;95%CI,-11.7至13.3)。
适用人群与场景
- 极早产儿(<28周妊娠)活产儿,来自EPICE-SHIPS人群队列(11个欧洲国家19个地区,2011至2012年出生),最终996例(478例女性,48.0%)有至少1项结局数据。
研究设计与关键结果
- 研究类型:基于EPICE-SHIPS研究的人群队列研究;总队列4395例极早产儿,活产2522例,存活至5岁1654例,随访996例(478例女性,48.0%)有至少1项结局数据。
- 暴露:5分钟Apgar评分分为0-3、4-6、7-8、9-10分四组;主要结局为5岁时认知(Wechsler学前及初小智力量表IQ)和运动(Movement Assessment Battery for Children-Second Edition)评分,次要结局为家长报告的ASQ-3沟通与问题解决技能,均为连续变量。
- 校正社会人口学变量、围产期因素和严重新生儿疾病后,Apgar评分≤3分(vs 9-10分)与IQ无关联(β=-3.3;95%CI,-10.5至3.8)。
- Apgar评分≤3分(vs 9-10分)与ASQ-3无关联(β=-2.1;95%CI,-24.6至20.4)。
- Apgar评分≤3分(vs 9-10分)与运动评分无关联(β=-4.0;95%CI,-20.1至12.1);排除脑瘫患儿后,β=0.8(95%CI,-11.7至13.3)。
证据类型、等级与局限
- 证据类型:人群队列研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,极早产儿中低Apgar评分与远期结局无关联,可能与Apgar评分观察者间变异大、极早产儿出生后活力体征减少和对复苏反应差,以及新生儿重症监护病房中更多有害暴露或社会经济因素与生后5年结局更大变化相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The Apgar score is used worldwide as an assessment tool to estimate the vitality of newborns in their first minutes of life. Its applicability to estimate neurodevelopmental outcomes in infants born extremely preterm (EPT; <28 weeks' gestation) is not well established.
OBJECTIVE: To investigate the association between the Apgar score and neurodevelopmental outcomes in infants born EPT.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted using data from the Effective Perinatal Intensive Care in Europe-Screening to Improve Health in Very Preterm Infants in Europe (EPICE-SHIPS) study, a population-based cohort in 19 regions of 11 European countries in 2011 to 2012. Clinical assessments of cognition and motor function at age 5 years were performed in infants born EPT and analyzed in January to July 2023.
EXPOSURES: Apgar score at 5 minutes of life categorized into 4 groups (0-3, 4-6, 7-8, and 9-10 points).
MAIN OUTCOMES AND MEASURES: Cognitive and motor outcomes were assessed using the Wechsler Preschool and Primary Scale of Intelligence test of IQ derived from locally normed versions by country and the Movement Assessment Battery for Children-Second Edition. Parents additionally provided information on communication and problem-solving skills using the Ages and Stages Questionnaire, third edition (ASQ-3). All outcomes were measured as continuous variables.
RESULTS: From the total cohort of 4395 infants born EPT, 2522 infants were live born, 1654 infants survived to age 5 years, and 996 infants (478 females [48.0%]) followed up had at least 1 of 3 outcome measures. After adjusting for sociodemographic variables, perinatal factors, and severe neonatal morbidities, there was no association of Apgar score with IQ, even for scores of 3 or less (β = -3.3; 95% CI, -10.5 to 3.8) compared with the score 9 to 10 category. Similarly, no association was found for ASQ-3 (β = -2.1; 95% CI, -24.6 to 20.4). Congruent results for Apgar scores of 3 or less were obtained for motor function scores for all children (β = -4.0; 95% CI, -20.1 to 12.1) and excluding children with a diagnosis of cerebral palsy (β = 0.8, 95% CI -11.7 to 13.3).
CONCLUSIONS AND RELEVANCE: This study found that low Apgar scores were not associated with longer-term outcomes in infants born EPT. This finding may be associated with high interobserver variability in Apgar scoring, reduced vitality signs and poorer responses to resuscitation after birth among infants born EPT, and the association of more deleterious exposures in the neonatal intensive care unit or of socioeconomic factors with greater changes in outcomes during the first 5 years of life.
参考来源
- Ehrhardt H, Aubert AM, Ådén U, et al. Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm. JAMA Netw Open. 2023. PMID: 37672271. doi:10.1001/jamanetworkopen.2023.32413
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。